This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Alaunos Therapeutics And The National Cancer Institute Extend Cooperative Research And Development Agreement For Development Of Personalized TCR-T Cell Therapies To 2025
Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (NASDAQ:TCRT), a clinical-stage oncology-focused cell therapy company, today announced that the Company has extended its Cooperative
Carnival Surges Over 12%, Here’s 75 Biggest Movers From Friday
Gainers
USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Zendesk, Quotient, + 40 Stocks Moving In Friday’s Mid-Day Session
Gainers
USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
25 Stocks Moving in Friday’s Pre-Market Session
Gainers
Regis Corporation (NYSE: RGS) rose 74.4% to $0.9753 in pre-market trading. Regis partnered with salon technology provider Zenoti to support its 5,000+ locations.
Alaunos Therapeutics Shares Earlier Spiked Over 100% in Premarket; Company is Presenting Friday at Jefferies Healthcare Conference at 8:00 AM ET
https://wsw.com/webcast/jeff240/tcrt/1865325
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Sana Biotechnology (NASDAQ:SANA) shares moved upwards by 9.1% to $6.1 during Friday's after-market session. The company's market cap stands at $1.1 billion.
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell
• AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.